Challenges and improvement in management of neonates born to mothers with COVID-19 in China

Abstract

Objective: China was the first country suffering from the SARS-CoV-2 pandemic and one of the countries with stringent mother-neonate isolation measure implemented. Now increasing evidence suggests that coronavirus disease 2019 (COVID-19) should not be taken as an indication for formula feeding or isolation of the infant from the mother.
Methods: We conducted a retrospective cohort study in 44 hospitals from 14 provinces in China to investigate the management of neonates whose mothers have confirmed or suspected COVID-19. In addition, 65 members of Chinese Neonatologist Association (CNA) were invited to give their comments and suggestions on the clinical management guidelines for high-risk neonates.
Results: There were 121 neonates born to 118 mothers suspected with COVID-19 including 42 mothers with SARS-CoV-2 positive results and 76 mothers with SARS-CoV-2 negative results. All neonates were born by caesarean section, isolated from their mothers immediately after birth and were formula-fed. Five neonates were positive for SARSCoV-2 at initial testing between 36 and 46 h after birth. Regarding the confusion on the clinical management guidelines, 58.78% of the newborns were put into isolation, 32.22% were subject to PCR tests, and 5.16% and 2.75% received breastfeeding and vaccination, respectively.
Conclusion: The clinical symptoms of neonates born to mothers with confirmed SARS-CoV-2 were mild, though five neonates might have been infected in utero or during delivery. Given the favorable outcomes of neonates born to COVID-confirmed mothers, full isolation may not be warranted. Rather, separation of the mother and her newborn should be assessed on a case-by-case basis, considering local facilities and risk factors for adverse outcomes, such as prematurity and fetal distress.

Keywords

coronavirus disease 2019 / neonates / pregnant women / infection control

References

[[1]] World Health Organization. Coronavirus disease (COVID-19) Situation dashboard. Geneva: World Health Organization, 2021.

[[2]] National Health Commission of the People’s Republic of China. The latest situation of novel coronavirus pneumonia as of 24:00 on 17 September 2021. Available at: http://www.nhc.gov.cn/wjw/index.shtml. Accessed on Sep 17, 2021. (Chinese).

[[3]] Yang J, Feng Z C. On behalf of the Chinese Neonatologist Association. Proposed management on 2019 novel coronavirus infection in neonates. Chin J Perinat Med, 2020; 23: 80-82. (Chinese).

[[4]] Wang J H, Qi H B, Bao L, et al. A contingency plan for the management of the 2019 novel coronavirus outbreak in neonatal intensive care units. Lancet Child Adolesc Health, 2020; 4(4): 258-259.

[[5]] Li F, Feng Z C, Shi Y. Proposal for prevention and control of the 2019 novel coronavirus disease in newborn infants. Arch Dis Child Fetal Neonatal Ed, 2020; 105(6): fetalneonatal-2020-318996.

[[6]] Chen L, Li Q, Zheng D, et al. Clinical characteristics of pregnant women with Covid-19 in Wuhan, China. N Engl J Med, 2020; 382(25): e100.

[[7]] Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet, 2020; 395(10226): 809-815.

[[8]] Zeng L, Xia S, Yuan W, et al. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr, 2020; 174(7): 722-725.

[[9]] Zhu H, Wang L, Fang C, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr, 2020; 9(1): 51-60.

[[10]] Yu N, Li W, Kang Q, et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet Infect Dis, 2020; 20(5): 559-564.

[[11]] Walker K F, O’Donoghue K, Grace N, Dorling J, Comeau J L, Li W, et al. Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis. BJOG, 2020; 127(11): 1324-1336.

[[12]] Salvatore C M, Han J Y, Acker K P, et al. Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study. Lancet Child Adolesc Health, 2020; 4(10): 721-727.

[[13]] National Health Commission of the People’s Republic of China. New coronavirus pneumonia prevention and control program (6th edition). Available at: http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml. Accessed on Oct 5, 2020.

[[14]] National Health Commission of the People’s Republic of China. Guideline for laboratory testing of new coronary virus pneumonia. Available at: http://www.nhc.gov.cn/xcs/zhengcwj/202002/a5d6f7b8c48c451c87dba14889b30147/files/3514cb996ae24e2faf65953b4ecd0df4.pdf. Accessed on Oct 5, 2020. (Chinese).

[[15]] Lokken E M, Walker C L, Delaney S, et al. Clinical characteristics of 46 pregnant women with a SARS-CoV-2 infection in Washington State. Am J Obstet Gynecol, 2020; 223(6): 911.e1-911.e14.

[[16]] Schmid MB, Fontijn J, Ochsenbein-Kölble N, et al. COVID-19 in pregnant women. Lancet Infect Dis, 2020; 20(6): 652-653.

[[17]] Breslin N, Baptiste C, Gyamfi-Bannerman C, et al. COVID-19 infection among asymptomatic and symptomatic pregnant women:Two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM, 2020; 2(2): 100118.

[[18]] Knight M, Bunch K, Vousden N, et al. Characteristics and outcomes of pregnant women hospitalised with confirmed SARS-CoV-2 infection in the UK: a national cohort study using the UK Obstetric Surveillance System (UKOSS). BMJ, 2020; 369: m2107.

[[19]] Landelle C, Pagani L, Harbarth S. Is patient isolation the single most important measure to prevent the spread of multidrug-resistant pathogens? Virulence, 2013; 4(2): 163-171.

[[20]] Sprague E, Reynolds S, Brindley P. Patient isolation precautions: are they worth it? Canadian Respiratory Journal, 2016; 2016: 5352625.

[[21]] World Health Organization. Q&A: Breastfeeding and COVID-19. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/q-a-on-covid-19-and-breastfeeding. Accessed on May 7, 2020.

[[22]] Chambers C D, Krogstad P, Bertrand K, et al. Evaluation of SARS- CoV-2 in breastmilk from 18 infected women. medrXiv 2020; published online June 16. DOI:10.1101/2020.06.12.20127944. (preprint).

[[23]] AAP issues guidance on infants born to mothers with suspected or confirmed COVID-19. Available at: https://www.aappublications.org/news/2020/04/02/infantcovidguidance040220. Accessed on May 7, 2020.

[[24]] Favre G, Pomar L, Qi X, et al. Guidelines for pregnant women with suspected SARS-CoV-2 infection. Lancet Infect Dis, 2020; 20(6): 652-653.

[[25]] Salvatore C M, Han J Y, Acker K P, et al. Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study. Lancet Child Adolesc Health, 2020, 4(10): 721-727.